Awarded contract

Glo-BNHL Central Review of Imaging and Clinical Data

Details

Buyer: University of Birmingham
Supplier(s): Medidata Solutions International Limited London
Value: £685,056.07
Topic: Medical imaging services
Published: 21 January 2025
Source: uk:find_a_tender

Tender description

Glo-BNHL is an international multi-arm clinical trial developed in collaboration with a number of key childhood cancer research organisations, including Innovative Therapies for Children with Cancer (ITCC) and the European Intergroup for Childhood NHL (EICNHL) in Europe, and the Children's Oncology Group (COG) in North America. The trial will be delivered globally with support from these organisations and in partnership with the C17 Council in Canada and the Australia and New Zealand Children's Haematology and Oncology Group (ANZCHOG). The trial is jointly funded by Cancer Research UK, Fight Kids Cancer and industry collaborators (currently ADC Therapeutics and Regeneron Pharmaceuticals). The funding provided is contingent upon the use of vendors with a track record of delivering clinical trials of this kind. The Cancer Research UK Clinical Trials Unit (CRCTU) at the University of Birmingham is not able to perform central review of imaging and clinical data, therefore a suitable third-party vendor must be engaged for this critical work. Lot 1: Glo-BNHL is an international multi-arm clinical trial developed in collaboration with a number of key childhood cancer research organisations, including Innovative Therapies for Children with Cancer (ITCC) and the European Intergroup for Childhood NHL (EICNHL) in Europe, and the Children's Oncology Group (COG) in North America. The trial will be delivered globally with support from these organisations and in partnership with the C17 Council in Canada and the Australia and New Zealand Children's Haematology and Oncology Group (ANZCHOG). The trial is jointly funded by Cancer Research UK, Fight Kids Cancer and industry collaborators (currently ADC Therapeutics and Regeneron Pharmaceuticals). The funding provided is contingent upon the use of vendors with a track record of delivering clinical trials of this kind. The Cancer Research UK Clinical Trials Unit (CRCTU) at the University of Birmingham is not able to perform central review of imaging and clinical data, therefore a suitable third-party vendor must be engaged for this critical work.

Timeline

Completed: Award date13 December 2024
Completed: Award published21 January 2025
Current notice

About the buyer

University of Birmingham is a higher education organisation whose central Procurement Division buys on behalf of its colleges, departments and professional services. Framework agreements arranged through regional consortia set fixed terms, service levels and pricing, and a purchase is committed only once an order is placed. The University also runs its own Build Higher Framework for construction projects, appointing five approved contractors to deliver against it.

Over the past 5 years, most of University of Birmingham's contract awards have been in business services, software and information systems and research and development.

Decision makers

Connect with the people behind this procurement.

Job title	Phone number	Work email
Head of Procurement	+44 •••• ••••••	••••••••@university-of-birmingham.gov
Commercial Director	+44 •••• ••••••	••••••••@university-of-birmingham.gov
Procurement Manager	+44 •••• ••••••	••••••••@university-of-birmingham.gov
Category Lead	+44 •••• ••••••	••••••••@university-of-birmingham.gov
Senior Buyer	+44 •••• ••••••	••••••••@university-of-birmingham.gov
Contracts Manager	+44 •••• ••••••	••••••••@university-of-birmingham.gov